Lyfetec, Inc. (Formerly Tri-Star Holdings, Inc.) Receives Official FDA Registration Approval

FT. LAUDERDALE, FL--(Marketwire - April 15, 2009) - LYFETEC, Inc., formerly Tri-Star Holdings, Inc. (PINKSHEETS: TSHL) has officially received approval of its FDA registration. The company filed the registration in order to become an FDA approved medical distribution company. This registration enables the company to sell and distribute approved medical products throughout the U.S., effective immediately. Previously, the company had CE status (for the approval of certain international distribution). "The approved FDA registered status ensures our potential for revenues through the U.S. distribution of our test kits and other FDA approved medical products. While we cannot presently forecast revenues for the company from the expansion throughout the U.S. market, we are obviously very excited about our prospects and will initiate demographic and market analysis for such," said LyfeTec Executive Vice President and COO Steven Cohen. "We have already initiated the design process for packaging and print collateral for both the domestic and international markets," he added.

Management also noted that it expects the delivery of the UCHB dividend shares to the company's shareholders to be processed this week.

Safe Harbor Act Disclaimer: Forward-looking statements in this release are made pursuant to the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to certain risks, and uncertainties and actual results could differ from those discussed. This material is information only and is not an offer or solicitation to buy or sell the securities.